Cargando…

Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay

BACKGROUND AND AIM: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters cells through the binding of the viral spike protein with human angiotensin-converting enzyme 2 (ACE2), resulting in the development of coronavirus disease 2019 (COVID-19). To date, few antiviral drugs are availa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Guan-Yu, Pan, Yi-Cheng, Wu, Tung-Ying, Yao, Tsung-You, Wang, Wei-Jan, Shen, Wan-Jou, Ahmed, Azaj, Chan, Shu-Ting, Tang, Chih-Hsin, Huang, Wei-Chien, Hung, Mien-Chie, Yang, Juan-Cheng, Wu, Yang-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443859/
https://www.ncbi.nlm.nih.gov/pubmed/34549024
http://dx.doi.org/10.1016/j.jtcme.2021.09.002
_version_ 1784568379890204672
author Chen, Guan-Yu
Pan, Yi-Cheng
Wu, Tung-Ying
Yao, Tsung-You
Wang, Wei-Jan
Shen, Wan-Jou
Ahmed, Azaj
Chan, Shu-Ting
Tang, Chih-Hsin
Huang, Wei-Chien
Hung, Mien-Chie
Yang, Juan-Cheng
Wu, Yang-Chang
author_facet Chen, Guan-Yu
Pan, Yi-Cheng
Wu, Tung-Ying
Yao, Tsung-You
Wang, Wei-Jan
Shen, Wan-Jou
Ahmed, Azaj
Chan, Shu-Ting
Tang, Chih-Hsin
Huang, Wei-Chien
Hung, Mien-Chie
Yang, Juan-Cheng
Wu, Yang-Chang
author_sort Chen, Guan-Yu
collection PubMed
description BACKGROUND AND AIM: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters cells through the binding of the viral spike protein with human angiotensin-converting enzyme 2 (ACE2), resulting in the development of coronavirus disease 2019 (COVID-19). To date, few antiviral drugs are available that can effectively block viral infection. This study aimed to identify potential natural products from Taiwan Database of Extracts and Compounds (TDEC) that may prevent the binding of viral spike proteins with human ACE2 proteins. METHODS: The structure-based virtual screening was performed using the AutoDock Vina program within PyRX software, the binding affinities of compounds were verified using isothermal titration calorimetry (ITC), the inhibitions of SARS-CoV-2 viral infection efficacy were examined by lentivirus particles pseudotyped (Vpp) infection assay, and the cell viability was tested by 293T cell in MTT assay. RESULTS AND CONCLUSION: We identified 39 natural products targeting the viral receptor-binding domain (RBD) of the SARS-CoV-2 spike protein in silico. In ITC binding assay, dioscin, celastrol, saikosaponin C, epimedin C, torvoside K, and amentoflavone showed dissociation constant (K(d)) = 0.468 μM, 1.712 μM, 6.650 μM, 2.86 μM, 3.761 μM and 4.27 μM, respectively. In Vpp infection assay, the compounds have significantly and consistently inhibition with the 50–90% inhibition of viral infection efficacy. In cell viability, torvoside K, epimedin, amentoflavone, and saikosaponin C showed IC(50) > 100 μM; dioscin and celastrol showed IC(50) = 1.5625 μM and 0.9866 μM, respectively. These natural products may bind to the viral spike protein, preventing SARS-CoV-2 from entering cells. SECTION: 1: Natural Products. TAXONOMY (CLASSIFICATION BY EVISE): SARS-CoV-2, Structure-Based Virtual Screening, Isothermal Titration Calorimetry and Lentivirus Particles Pseudotyped (Vpp) Infection Assay, in silico and in vitro study.
format Online
Article
Text
id pubmed-8443859
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84438592021-09-16 Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay Chen, Guan-Yu Pan, Yi-Cheng Wu, Tung-Ying Yao, Tsung-You Wang, Wei-Jan Shen, Wan-Jou Ahmed, Azaj Chan, Shu-Ting Tang, Chih-Hsin Huang, Wei-Chien Hung, Mien-Chie Yang, Juan-Cheng Wu, Yang-Chang J Tradit Complement Med Article BACKGROUND AND AIM: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters cells through the binding of the viral spike protein with human angiotensin-converting enzyme 2 (ACE2), resulting in the development of coronavirus disease 2019 (COVID-19). To date, few antiviral drugs are available that can effectively block viral infection. This study aimed to identify potential natural products from Taiwan Database of Extracts and Compounds (TDEC) that may prevent the binding of viral spike proteins with human ACE2 proteins. METHODS: The structure-based virtual screening was performed using the AutoDock Vina program within PyRX software, the binding affinities of compounds were verified using isothermal titration calorimetry (ITC), the inhibitions of SARS-CoV-2 viral infection efficacy were examined by lentivirus particles pseudotyped (Vpp) infection assay, and the cell viability was tested by 293T cell in MTT assay. RESULTS AND CONCLUSION: We identified 39 natural products targeting the viral receptor-binding domain (RBD) of the SARS-CoV-2 spike protein in silico. In ITC binding assay, dioscin, celastrol, saikosaponin C, epimedin C, torvoside K, and amentoflavone showed dissociation constant (K(d)) = 0.468 μM, 1.712 μM, 6.650 μM, 2.86 μM, 3.761 μM and 4.27 μM, respectively. In Vpp infection assay, the compounds have significantly and consistently inhibition with the 50–90% inhibition of viral infection efficacy. In cell viability, torvoside K, epimedin, amentoflavone, and saikosaponin C showed IC(50) > 100 μM; dioscin and celastrol showed IC(50) = 1.5625 μM and 0.9866 μM, respectively. These natural products may bind to the viral spike protein, preventing SARS-CoV-2 from entering cells. SECTION: 1: Natural Products. TAXONOMY (CLASSIFICATION BY EVISE): SARS-CoV-2, Structure-Based Virtual Screening, Isothermal Titration Calorimetry and Lentivirus Particles Pseudotyped (Vpp) Infection Assay, in silico and in vitro study. Elsevier 2021-09-16 /pmc/articles/PMC8443859/ /pubmed/34549024 http://dx.doi.org/10.1016/j.jtcme.2021.09.002 Text en © 2021 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier Taiwan LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Chen, Guan-Yu
Pan, Yi-Cheng
Wu, Tung-Ying
Yao, Tsung-You
Wang, Wei-Jan
Shen, Wan-Jou
Ahmed, Azaj
Chan, Shu-Ting
Tang, Chih-Hsin
Huang, Wei-Chien
Hung, Mien-Chie
Yang, Juan-Cheng
Wu, Yang-Chang
Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay
title Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay
title_full Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay
title_fullStr Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay
title_full_unstemmed Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay
title_short Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay
title_sort potential natural products that target the sars-cov-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (vpp) infection assay
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443859/
https://www.ncbi.nlm.nih.gov/pubmed/34549024
http://dx.doi.org/10.1016/j.jtcme.2021.09.002
work_keys_str_mv AT chenguanyu potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay
AT panyicheng potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay
AT wutungying potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay
AT yaotsungyou potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay
AT wangweijan potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay
AT shenwanjou potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay
AT ahmedazaj potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay
AT chanshuting potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay
AT tangchihhsin potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay
AT huangweichien potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay
AT hungmienchie potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay
AT yangjuancheng potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay
AT wuyangchang potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay